These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 29846247

  • 1. Co-delivery of paclitaxel and gemcitabine by methoxy poly(ethylene glycol)-poly(lactide-coglycolide)-polypeptide nanoparticles for effective breast cancer therapy.
    Dong S, Guo Y, Duan Y, Li Z, Wang C, Niu L, Wang N, Ma M, Shi Y, Zhang M.
    Anticancer Drugs; 2018 Aug; 29(7):637-645. PubMed ID: 29846247
    [Abstract] [Full Text] [Related]

  • 2. Co-Delivery of Gemcitabine and Paclitaxel in cRGD-Modified Long Circulating Nanoparticles with Asymmetric Lipid Layers for Breast Cancer Treatment.
    Zhang J, Zhang P, Zou Q, Li X, Fu J, Luo Y, Liang X, Jin Y.
    Molecules; 2018 Nov 07; 23(11):. PubMed ID: 30405089
    [Abstract] [Full Text] [Related]

  • 3. Synthesis of a gemcitabine-modified phospholipid and its subsequent incorporation into a single microbubble formulation loaded with paclitaxel for the treatment of pancreatic cancer using ultrasound-targeted microbubble destruction.
    Logan KA, Nesbitt H, Callan B, Gao J, McKaig T, Taylor M, Love M, McHale AP, Callan JF.
    Eur J Pharm Biopharm; 2021 Aug 07; 165():374-382. PubMed ID: 34038797
    [Abstract] [Full Text] [Related]

  • 4. A co-delivery system based on paclitaxel grafted mPEG-b-PLG loaded with doxorubicin: preparation, in vitro and in vivo evaluation.
    Li Q, Lv S, Tang Z, Liu M, Zhang D, Yang Y, Chen X.
    Int J Pharm; 2014 Aug 25; 471(1-2):412-20. PubMed ID: 24905776
    [Abstract] [Full Text] [Related]

  • 5. Use of a lipid-coated mesoporous silica nanoparticle platform for synergistic gemcitabine and paclitaxel delivery to human pancreatic cancer in mice.
    Meng H, Wang M, Liu H, Liu X, Situ A, Wu B, Ji Z, Chang CH, Nel AE.
    ACS Nano; 2015 Aug 25; 9(4):3540-57. PubMed ID: 25776964
    [Abstract] [Full Text] [Related]

  • 6. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.
    Zhang L, Zhu D, Dong X, Sun H, Song C, Wang C, Kong D.
    Int J Nanomedicine; 2015 Aug 25; 10():2101-14. PubMed ID: 25844039
    [Abstract] [Full Text] [Related]

  • 7. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.
    Wang H, Zhao Y, Wu Y, Hu YL, Nan K, Nie G, Chen H.
    Biomaterials; 2011 Nov 25; 32(32):8281-90. PubMed ID: 21807411
    [Abstract] [Full Text] [Related]

  • 8. Precise engineering of hybrid molecules-loaded macromolecular nanoparticles shows in vitro and in vivo antitumor efficacy toward the treatment of nasopharyngeal cancer cells.
    Liu D, Zhang W, Liu X, Qiu R.
    Drug Deliv; 2021 Dec 25; 28(1):776-786. PubMed ID: 33866910
    [Abstract] [Full Text] [Related]

  • 9. Thermosensitive poly-(d,l-lactide-co-glycolide)-block-poly(ethylene glycol)-block-poly-(d,l-lactide-co-glycolide) hydrogels for multi-drug delivery.
    Cho H, Kwon GS.
    J Drug Target; 2014 Aug 25; 22(7):669-77. PubMed ID: 24964052
    [Abstract] [Full Text] [Related]

  • 10. Co-delivery of gemcitabine and cisplatin via Poly (L-glutamic acid)-g-methoxy poly (ethylene glycol) micelle to improve the in vivo stability and antitumor effect.
    Ding N, Zhao Z, Yin N, Xu Y, Yin T, Gou J, He H, Wang Y, Zhang Y, Tang X.
    Pharm Res; 2021 Dec 25; 38(12):2091-2108. PubMed ID: 34893950
    [Abstract] [Full Text] [Related]

  • 11. Self-assembly of biotinylated poly(ethylene glycol)-poly(curcumin) for paclitaxel delivery.
    Hu L, Li M, Zhang Z, Shen Y, Guo S.
    Int J Pharm; 2018 Dec 20; 553(1-2):510-521. PubMed ID: 30308274
    [Abstract] [Full Text] [Related]

  • 12. Smart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomes.
    Jin M, Jin G, Kang L, Chen L, Gao Z, Huang W.
    Int J Nanomedicine; 2018 Dec 20; 13():2405-2426. PubMed ID: 29719390
    [Abstract] [Full Text] [Related]

  • 13. High Loading of Hydrophobic and Hydrophilic Agents via Small Immunostimulatory Carrier for Enhanced Tumor Penetration and Combinational Therapy.
    Sun J, Chen Y, Xu J, Song X, Wan Z, Du Y, Ma W, Li X, Zhang L, Li S.
    Theranostics; 2020 Dec 20; 10(3):1136-1150. PubMed ID: 31938056
    [Abstract] [Full Text] [Related]

  • 14. Development and evaluation of a novel TPGS-mediated paclitaxel-loaded PLGA-mPEG nanoparticle for the treatment of ovarian cancer.
    Lv W, Cheng L, Li B.
    Chem Pharm Bull (Tokyo); 2015 Dec 20; 63(2):68-74. PubMed ID: 25451039
    [Abstract] [Full Text] [Related]

  • 15. Development and characterization of stabilized double loaded mPEG-PDLLA micelles for simultaneous delivery of paclitaxel and docetaxel.
    Ouahab A, Shao C, Shen Y, Tu J.
    Drug Dev Ind Pharm; 2014 Jul 20; 40(7):860-8. PubMed ID: 23600653
    [Abstract] [Full Text] [Related]

  • 16. Thermo- and pH-responsive targeted lipid-coated mesoporous nano silica platform for dual delivery of paclitaxel and gemcitabine to overcome HER2-positive breast cancer.
    Nasri N, Saharkhiz S, Dini G, Yousefnia S.
    Int J Pharm; 2023 Dec 15; 648():123606. PubMed ID: 37972671
    [Abstract] [Full Text] [Related]

  • 17. Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ɛ-caprolactone) nanoparticles: In vitro and in vivo evaluation.
    Xin H, Chen L, Gu J, Ren X, Wei Z, Luo J, Chen Y, Jiang X, Sha X, Fang X.
    Int J Pharm; 2010 Dec 15; 402(1-2):238-47. PubMed ID: 20934500
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and evaluation of a paclitaxel-binding polymeric micelle for efficient breast cancer therapy.
    Xiang J, Wu B, Zhou Z, Hu S, Piao Y, Zhou Q, Wang G, Tang J, Liu X, Shen Y.
    Sci China Life Sci; 2018 Apr 15; 61(4):436-447. PubMed ID: 29572777
    [Abstract] [Full Text] [Related]

  • 19. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
    Zhang F, Wang X, Xu X, Li M, Zhou J, Wang W.
    Eur J Pharm Sci; 2016 Sep 20; 92():11-21. PubMed ID: 27343697
    [Abstract] [Full Text] [Related]

  • 20. RETRACTED: Enhanced antitumor efficacy of 5-fluorouracil loaded methoxy poly(ethylene glycol)-poly(lactide) nanoparticles for efficient therapy against breast cancer.
    Yuan Z, Qu X, Wang Y, Zhang DY, Luo JC, Jia N, Zhang ZT.
    Colloids Surf B Biointerfaces; 2015 Apr 01; 128():489-497. PubMed ID: 25779606
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.